To which extent are MA and MO interrelated? The great majority of patients who suffer from MO have never had an attack of MA. On the other hand, among patients who have attacks of MA, it is very common to also have attacks of MO. In population-based studies, the co-occurrence of MA and MO in individual patients was not more frequent than expected than by chance, but in clinic materials it was markedly more frequent (
5,
13,
14). It is a common clinical observation, although never scientifically documented, that MO may change into MA and vice versa. A person may for years suffer exclusively from one form and then later from the other form or from both forms, but it remains uncertain whether this occurrence is greater than by chance. MA and MO both respond to 5-hydroxytryptamine (5-HT
1) receptor agonists (see
Chapter 51). It is a generally accepted clinical experience that both forms of migraine also respond to ergot preparations, but this has never been scientifically documented. A methodologically sound and reasonably powerful double-blind trial of metoprolol in the prophylactic treatment of MA showed an effect quite similar to the effect in several trials of MO (
9). It thus looks as if the two forms of migraine generally respond to the same treatments. A large number of pathophysiologic studies have shown that dilatation of large intra- and extracranial arteries occurs in both forms of migraine during an attack but that regional cerebral blood flow changes, other than those secondary to pain activation, are present only in MA (see
Chapter 37).
Genetic epidemiologic studies and twin studies have shown that MA has a higher familial risk and a higher concordance rate than MO (
Chapter 27). Finally, glyceryl trinitrate, which effectively induces attacks without aura in MO sufferers, does not provoke an aura but provokes an attack of MO in patients suffering exclusively from MA (
4). The most reasonable interpretation of these interrelationships is that initiating mechanisms are different, although
the painful phase and its associated symptoms are shared by the two forms of migraine (
Fig. 24-1).